posted on 2017-12-20, 00:00authored byMengqi Huang, Xiaoming Zhou, Huiying Wang, Da Xing
A novel
CRISPR/Cas9 triggered isothermal exponential amplification
reaction (CAS-EXPAR) strategy based on CRISPR/Cas9 cleavage and nicking
endonuclease (NEase) mediated nucleic acids amplification was developed
for rapid and site-specific nucleic acid detection. CAS-EXPAR was
primed by the target DNA fragment produced by cleavage of CRISPR/Cas9,
and the amplification reaction performed cyclically to generate a
large number of DNA replicates which were detected using a real-time
fluorescence monitoring method. This strategy that combines the advantages
of CRISPR/Cas9 and exponential amplification showed high specificity
as well as rapid amplification kinetics. Unlike conventional nucleic
acids amplification reactions, CAS-EXPAR does not require exogenous
primers, which often cause target-independent amplification. Instead,
primers are first generated by Cas9/sgRNA directed site-specific cleavage
of target and accumulated during the reaction. It was demonstrated
this strategy gave a detection limit of 0.82 amol and showed excellent
specificity in discriminating single-base mismatch. Moreover, the
applicability of this method to detect DNA methylation and L. monocytogenes total RNA was also verified. Therefore,
CAS-EXPAR may provide a new paradigm for efficient nucleic acid amplification
and hold the potential for molecular diagnostic applications.